NMK89

89Zr-labeled hNd2 radiotracer · Nihon Medi-Physics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NMK89, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer [Phase 1]

See pricing